Back

Relationship of natriuretic peptides with left atrial function within 1 month after electrical cardioversion in patients with persistent atrial fibrillation

7 December 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Echocardiography: Dimensions, Volumes and Mass Morphology, Dimensions, Volumes and Mass EACVI Premium Access EuroEcho-Imaging 2018

About the speaker

Photo
Miss Justina Jureviciute

Kaunas Clinics, Kaunas (Lithuania)

8 More presentations in this session

Presentation thumbnail
Doctor M. Annabi (Quebec, CA)
Abstract Slides
Presentation thumbnail
Doctor M. Kim (Seoul, KR)
Abstract
Presentation thumbnail
Ms S. Kojima (Nagasaki, JP)
Abstract Slides
Presentation thumbnail
Doctor F. Olsen (Copenhagen, DK)
Abstract
Presentation thumbnail
Doctor G. Masson Juarez (Buenos Aires, AR)
Abstract

Access the full session

Session thumbnail
Poster session 4 - Echocardiography: Dimensions, Volumes and Mass

The Event

Event poster

EuroEcho-Imaging 2018

7 December 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Evaluation of the diagnostic significance of various types of natriuretic peptides in patients with heart failure on the background of atrial fibrillation and chronic obstructive pulmonary disease
29 June 2021
thumbnail
Congress Presentation
Atrial function after cardioversion in patients with persistent atrial fibrillation
1 September 2024
thumbnail
Congress Session
How to manage atrial fibrillation in heart failure
17 May 2025
thumbnail
Congress Presentation
Effects of sacubitril/valsartan on atrial function and structure as treatment response indicators in patients with heart failure with reduced ejection fraction: an observational prospective study.
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources